Eyelid warming is a fundamental feature of many therapies that help restore homeostasis in meibomian gland dysfunction (MGD). Heat melts otherwise inspissated oils and encourages outflow of meibum onto the lid margin to augment and stabilise the tear film lipid layer.
Selected from 3,900 nominations, Lumenis’ OptiLight technology for the treatment of dry eye disease (DED) has received MedTech Breakthrough’s Best New Technology Solution for Ophthalmology award.
We all look at faces and eyes every day. Be it refracting, screening for diabetic retinopathy, looking for retinal tears or monitoring glaucoma, we are looking closely. But do we see? Do we look for and see the nodular basal cell carcinoma at the medial canthus or the squamous cell carcinoma on the
Pilot evaluation for an image-based eyelid lesion management service
Alcon has signed a US$60 million agreement to acquire Kala Pharmaceuticals’ loteprednol etabonate products Eysuvis 0.25% for dry-eye disease (DED) and Inveltys 1%, for post-operative inflammation and pain.
American actress Kate Walsh has teamed up with Alcon to promote dry-eye health. Walsh, best known for her roles in Grey’s Anatomy and Emily in Paris, is sharing her dry-eye journey as part of Alcon’s new ‘Make Every Look Count’ campaign, coinciding with the launch of Alcon’s Systane Complete Preserv
New research shows 77% of Australians experience dry eye symptoms but many have no clear understanding of the signs, symptoms or causes. To help raise awareness about the prevalence of undiagnosed
The final Ocular Therapeutics Evening (OTE) of the University of Auckland’s Buchanan Ocular Therapeutics Unit (BOTU) series was held online and focused on paediatric eyecare.
Medix21 now offers a full suite of dry eye consumables following the introduction of the Eyestil Synfo dry eye disease (DED) drop.
Johnson & Johnson Vision has unveiled its next-generation TearScience Activator Clear for more precise and fully automated treatment of meibomian gland dysfunction (MGD). The new system features a
American actress and singer-songwriter Mandy Moore, the voice of Disney’s Princess Rapunzel, is a dry-eye sufferer and the new brand ambassador for Lumenis’ OptiLight.
Seattle start-up Olympic Ophthalmics has received US Food and Drug Administration (FDA) approval for its iTEAR100 device, a prescription neurostimulation therapy to increase tear production in adult
